S1PR1 as a Novel Promising Therapeutic Target in Cancer Therapy
Author:
Publisher
Springer Science and Business Media LLC
Subject
Pharmacology,Genetics,Molecular Medicine,General Medicine
Link
http://link.springer.com/content/pdf/10.1007/s40291-019-00401-5.pdf
Reference158 articles.
1. Weichand B, Popp R, Dziumbla S, Mora J, Strack E, Elwakeel E, et al. S1PR1 on tumor-associated macrophages promotes lymphangiogenesis and metastasis via NLRP3/IL-1beta. J Exp Med. 2017;214(9):2695–713. https://doi.org/10.1084/jem.20160392 .
2. Kunkel GT, Maceyka M, Milstien S, Spiegel S. Targeting the sphingosine-1-phosphate axis in cancer, inflammation and beyond. Nat Rev Drug Discov. 2013;12(9):688–702. https://doi.org/10.1038/nrd4099 .
3. Takabe K, Paugh SW, Milstien S, Spiegel S. “Inside-out” signaling of sphingosine-1-phosphate: therapeutic targets. Pharmacol Rev. 2008;60(2):181–95. https://doi.org/10.1124/pr.107.07113 .
4. Calis IU, Cosan DT, Mutlu F. Effects of S1P1 and S1P3 in ER(+) and ER(−) breast cancer cells. Anticancer Res. 2017;37(10):5469–75. https://doi.org/10.21873/anticanres.11976 .
5. Brocklyn JR. Regulation of cancer cell migration and invasion by sphingosine-1-phosphate. World J Biol Chem. 2010;1(10):307–12. https://doi.org/10.4331/wjbc.v1.i10.307 .
Cited by 32 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. S1PR1 regulates ovarian cancer cell senescence through the PDK1-LATS1/2-YAP pathway;Oncogene;2023-10-12
2. S1PR1 regulates ovarian cancer cell senescence through the PDK1-LATS1/2-YAP pathway;ONCOGENE;2023
3. Apolipoprotein M bound sphingosine 1-phosphate suppresses NETosis through activating S1P1 and S1P4;Biomedicine & Pharmacotherapy;2023-10
4. A functional polymorphism at the miR-25-3p binding site in the 3′-untranslated region of the S1PR1 gene decreases the risk of osteoporosis in Chinese postmenopausal women;Arabian Journal of Chemistry;2023-08
5. Effects of adipocyte-conditioned cell culture media on S1P treatment of human triple-negative breast cancer cells;PLOS ONE;2023-05-23
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3